Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Pembrolizumab for Patients with High-risk Non-Muscle-Invasive Bladder Cancer Unresponsive to BCG
Login to view comments.
Click here to Login
Updates in Oncology